IMRE CORP
8-K, 1996-03-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: DOMINION RESOURCES INC /VA/, 4, 1996-03-08
Next: STERLING SOFTWARE INC, 8-K, 1996-03-08



<PAGE>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC  20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                                  March 6, 1996
                 ----------------------------------------------
                Date of Report (Date of earliest event reported)


                                IMRE CORPORATION
                  ---------------------------------------------
             (Exact name of registrant as specified in its charter)




      Delaware                          0-12943                   22-2389839
- -------------------------      ---------------------------    ------------------
(State or other jurisdiction        (Commission                  (IRS Employer
     of incorporation)               File Number)            Identification No.)



                           401 Queen Anne Avenue North
                               Seattle, WA  98109
                   ------------------------------------------
                    (Address of principal executive offices)



                                 (206) 298-9400
                  --------------------------------------------
              (Registrant's telephone number, including area code)



                                                  Total number of pages:
                                                  Index to Exhibits at Page:

<PAGE>

ITEM 5. OTHER EVENTS

In January 1996, the Registrant sold 8,540,702 shares of Common Stock for $1.50
per share in a private placement.  The sales occurred pursuant to a series of
closings occurring on January 21, 1996, January 22, 1996 and January 26, 1996.
The net proceeds to the Company were approximately $12,000,000.  As a result of
the private placement, $1,500,000 of outstanding Senior Convertible Debentures
of the Registrant were automatically converted to 1,000,000 shares of the
Registrant's Common Stock.

On February 20, 1996, the Registrant filed with the Securities and Exchange
Commission a registration statement of Form S-3 under the Securities Act of
1933, as amended, for resale of the above-referenced shares.

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

     (c)  Exhibits.
          --------

          99.1.  Proforma Balance Sheet as of December 31, 1995

<PAGE>

                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                        IMRE CORPORATION



Dated:   March 6, 1996                  By:  /s/ ALEX P. DE SOTO
                                            ------------------------
                                            Alex P. de Soto
                                            Chief Financial Officer, Vice
                                            President and Secretary


<PAGE>
                                INDEX TO EXHIBITS



                                                                   PAGE NO.



    99.1      Proforma Balance Sheet as of December 31, 1995

<PAGE>

                                IMRE CORPORATION
                             PRO FORMA BALANCE SHEET
                                DECEMBER 31, 1995

                       -----------------------------------

<TABLE>
<CAPTION>

ASSETS                                              (AUDITED) 1995       ADJUSTMENTS          1995 PRO FORMA
- ------                                             ----------------     -------------        ----------------
<S>                                                <C>                  <C>                  <C>
Current assets:

   Cash and cash equivalents                         $  1,009,878       $ 12,103,080 (1)       $ 13,112,958
   Accounts receivable:
      Trade                                                23,850                                    23,850
      Other                                               533,989                                   533,989
   Inventories                                          1,148,506                                 1,148,506
   Prepaid expenses                                       143,755                                   143,755
                                                     ------------                              ------------
      Total current assets                              2,859,978                                14,963,058
                                                     ------------                              ------------

Property and equipment, net                             1,425,020                                 1,425,020
Convertible debenture issuance costs, net                 278,711           (140,000)(2)            138,711
                                                     ------------       ------------           ------------

      Total assets                                   $  4,563,709       $ 11,963,080           $ 16,526,789
                                                     ------------       ------------           ------------
                                                     ------------       ------------           ------------

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
- ----------------------------------------------

Current liabilities:

   Accounts payable                                  $    892,501                              $    892,501
   Accrued compensation                                   456,939                                   456,939
   Accrued liabilities                                    672,488       $     90,000 (3)            762,488
   Senior convertible debentures                        1,500,000         (1,500,000)(4)
   Current portion of notes payable                        26,821                                    26,821
                                                     ------------       ------------           ------------
      Total current liabilities                         3,548,749         (1,410,000)             2,138,749
                                                     ------------       ------------           ------------
                                                     ------------       ------------           ------------

Convertible debentures                                  1,345,000                                 1,345,000
Notes payable, net of current portion                      25,972                                    25,972
Accrued compensation                                      168,750                                   168,750
                                                     ------------                              ------------
                                                        5,088,471                                 3,678,471
                                                     ------------                              ------------
Commitments and contingencies

Stockholders' equity (deficit):
   Common stock, $.02 par value; authorized
      35,000,000 shares; issued and outstanding,
      18,693,595 shares at December 31, 1995              373,872            191,214 (5)            565,086
   Additional paid-in capital                          43,143,000         13,181,866 (6)         56,324,866
                                                     ------------       ------------           ------------
                                                       43,516,872         13,373,080             56,889,952
   Accumulated deficit                                (44,041,634)                              (44,041,634)
                                                     ------------       ------------           ------------
                                                         (524,762)        13,373,080             12,848,318
                                                     ------------       ------------           ------------
      Total liabilities and stockholders'
         equity (deficit)                            $  4,563,709       $ 11,963,080           $ 16,526,789
                                                     ------------       ------------           ------------
                                                     ------------       ------------           ------------
</TABLE>

(1)  Represents 8,540,702 shares of Common Stock sold in January 1996 at $1.50
     per share less $707,973 of placement agent fees.

<PAGE>

(2)  Represents placement agent fees and costs associated with issuing
     $1,500,000 principal of Senior Convertible Debentures as of December 31,
     1995 which were charged to Additional Paid-in Capital upon the conversion
     of the Debentures on January 22, 1996 into 1,000,000 shares of Common
     Stock.

(3)  Represents estimated legal and accounting fees and other costs of $120,000
     associated with the January 1996 private placement of 8,540,702 shares of
     Common Stock at $1.50 per share, less $30,000 of December 1995 Senior
     Convertible Debenture private placement fees paid in 20,000 shares of
     Common Stock at $1.50 per share in January 1996.

(4)  Represents the conversion of $1,500,000 principal of Senior Convertible
     Debentures on January 22, 1996 into 1,000,000 shares of Common Stock.

(5)  Represents the par value ($0.02) for the issuance of 9,560,702 shares of
     Common Stock in January 1996.

(6)  Represents the net increase in Additional Paid-in Capital of the issuance
     of 9,560,702 shares of Common Stock at $1.50 per share less their par value
     and offering costs.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission